Bettina Bisig Selected Research

Bettina Bisig Research Topics

Disease

11	Neoplasms (Cancer) 12/2022 - 10/2009
6	Lymphoma (Lymphomas) 12/2023 - 10/2009
4	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2012
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2023 - 08/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 12/2023 - 02/2023
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 03/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 02/2008
2	Liver Cell Adenoma (Hepatocellular Adenoma) 12/2017 - 04/2017
1	Fibrosis (Cirrhosis) 01/2024
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Lymphadenopathy 12/2022
1	Pericardial Effusion 12/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2022
1	COVID-19 07/2021
1	Uveal melanoma 10/2020
1	Follicular Adenocarcinoma 01/2020
1	Neurofibrosarcoma (MPNST) 12/2019
1	Neurofibromatoses (Neurofibromatosis) 12/2019
1	Adenocarcinoma 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Histiocytic Sarcoma 01/2018
1	Cholestasis 12/2017
1	Adenoma (Adenomas) 04/2017
1	Hepatocellular Carcinoma (Hepatoma) 04/2017
1	Fasciitis (Fascitis) 01/2017
1	Aggressive Fibromatosis (Desmoid) 01/2017
1	Papillary Thyroid Cancer 01/2017
1	Fibroma (Fibromatosis) 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 08/2013
1	Infections 08/2010
1	Squamous Intraepithelial Lesions 08/2010
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2009
1	Acute Cholecystitis 10/2009

Drug/Important Bio-Agent (IBA)

4	ParaffinIBA 07/2021 - 01/2017
4	CateninsIBA 12/2019 - 01/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2018
3	trametinibIBA 02/2023 - 01/2018
3	Formaldehyde (Formol)FDA Link 07/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2013
2	Reticulin (Reticular Fiber)IBA 01/2024 - 12/2017
2	CyclinsIBA 01/2019 - 02/2008
2	Biomarkers (Surrogate Marker)IBA 02/2016 - 03/2012
1	Anaplastic Lymphoma KinaseIBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Dasatinib (BMS 354825)FDA Link 12/2022
1	Tyrosine Kinase InhibitorsIBA 12/2022
1	FibrinIBA 03/2022
1	CytokinesIBA 01/2022
1	RacivirIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Cyclin D1IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	C-Reactive ProteinIBA 04/2017
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 04/2017
1	human ERBB2 proteinIBA 01/2017
1	IodineIBA 01/2017
1	AntibodiesIBA 08/2015
1	Tyrosine (L-Tyrosine)FDA Link 08/2013
1	Phosphotransferases (Kinase)IBA 08/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2013
1	Messenger RNA (mRNA)IBA 08/2013
1	Keratins (Keratin)IBA 05/2012
1	Periodic AcidIBA 05/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012
1	glucose-regulated proteinsIBA 03/2012
1	Natalizumab (Tysabri)FDA Link 06/2011
1	Viral AntigensIBA 08/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2010
1	Immunoglobulin D (IgD)IBA 10/2009
1	Cyclin D2IBA 02/2008

Therapy/Procedure

4	Therapeutics 02/2023 - 02/2016
1	Ligation 01/2020
1	Breast Implants (Breast Implant) 10/2018
1	Hepatectomy 04/2017
1	Organ Transplantation 01/2016
1	Splenectomy 06/2014
1	Drug Therapy (Chemotherapy) 03/2012
1	Cholecystectomy 10/2009